DMK PHARMACEUTICALS Corp Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2012 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
DMK PHARMACEUTICALS Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2012 to Q4 2022.
  • DMK PHARMACEUTICALS Corp Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $60.2M, a 11% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $60.2M +$5.97M +11% Dec 31, 2022 10-K 2023-03-16
Q4 2021 $54.3M +$9.52M +21.3% Dec 31, 2021 10-K 2023-03-16
Q4 2020 $44.7M +$7.76M +21% Dec 31, 2020 10-K 2022-03-31
Q4 2019 $37M +$8.65M +30.5% Dec 31, 2019 10-K 2021-04-15
Q4 2018 $28.3M +$7.5M +36% Dec 31, 2018 10-K 2020-03-30
Q4 2017 $20.8M +$600K +2.96% Dec 31, 2017 10-K 2019-03-15
Q4 2016 $20.2M +$2.47M +13.9% Dec 31, 2016 10-K 2018-03-16
Q4 2015 $17.8M +$5.9M +49.8% Dec 31, 2015 10-K 2017-03-30
Q4 2014 $11.9M Dec 31, 2014 10-K 2016-03-23
Q1 2014 $44.9M +$859K +1.95% Mar 31, 2014 10-KT 2015-03-26
Q1 2013 $44M +$2.71M +6.55% Mar 31, 2013 10-K 2014-06-23
Q1 2012 $41.3M Mar 31, 2012 10-K 2013-07-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.